Drug recall · June 1, 2022
Losartan HCTZ 50/12.5 mg recall
Why: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan HCTZ 50/12.5 mg, 90 count bottle Original NDC# 33342-0050-10 Repackaged NDC# 70518-3231-00
- Lots / codes
Lot # B1377711-100521, exp. date 10/31/2022 B1412137-102621, exp. date 10/31/2022
- Quantity
- 22 bottles/90 count each
- Company
- RemedyRepack Inc., Indiana, PA
- Distribution
- Recalled product was distributed to Florida.
- Initiated
- May 4, 2022 · Voluntary: Firm initiated
- Classified
- May 20, 2022
- Reported
- June 1, 2022
- Ended
- September 2, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide / losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.